First Foundation Advisors Illumina, Inc. Transaction History

First Foundation Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$181.58 - $368.0 $233,875 - $473,984	-1,288 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$303.87 - $423.8 $1,823 - $2,542	-6 Reduced 0.46%	1,288 $450,000
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $5,903 - $7,171	-17 Reduced 1.3%	1,294 $493,000
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $22,308 - $28,866	55 Added 4.38%	1,311 $532,000
Q2 2021 Aug 13, 2021	BUY	$372.84 - $481.5 $45,113 - $58,261	121 Added 10.66%	1,256 $594,000
Q1 2021 May 18, 2021	BUY	$361.28 - $504.76 $33,960 - $47,447	94 Added 9.03%	1,135 $436,000
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $74,053 - $93,852	253 Added 32.11%	1,041 $385,000
Q3 2020 Nov 12, 2020	BUY	$268.51 - $400.74 $211,585 - $315,783	788 New	788 $244,000
Q1 2020 May 11, 2020	SELL	$209.2 - $335.53 $136,189 - $218,430	-651 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$288.29 - $335.49 $14,414 - $16,774	-50 Reduced 7.13%	651 $216,000
Q3 2019 Nov 12, 2019	BUY	$266.84 - $378.23 $187,054 - $265,139	701 New	701 $213,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $23.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

Stay updated on First Foundation Advisors with notifications on news.